XRTX
NASDAQ · Pharmaceuticals
Xortx Therapeutics Inc
$2.08
+0.02 (+0.97%)
Open$2.02
Previous Close$2.06
Day High$2.10
Day Low$2.02
52W High$9.85
52W Low$2.42
Volume—
Avg Volume880
Market Cap5.19M
P/E Ratio—
EPS$-2.65
SectorPharmaceuticals
Analyst Ratings
Strong Buy
5 analysts
Price Target
+1,950.0% upside
Current
$2.08
$2.08
Target
$42.64
$42.64
$28.32
$42.64 avg
$47.79
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 73.66M | 92.30M | 1.25M |
| Net Income | -6,968,297 | -7,857,996 | 338.7K |
| Profit Margin | -2.6% | -2.5% | 27.0% |
| EBITDA | -8,252,062 | -9,822,652 | 499.5K |
| Free Cash Flow | — | — | 161.5K |
| Rev Growth | -20.2% | -20.2% | +20.7% |
| Debt/Equity | 0.02 | 0.02 | 0.65 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |